C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/14/2002	US20020169298 Methods and means for producing barley yellow dwarf virus resistant cereal plants
11/14/2002	US20020169295 Nucleotide sequences coding protein for use in the treatment, diagnosis and prevention of tumors and inflammatory bowel disease
11/14/2002	US20020169294 Method of purifying calcium ion-binding protein
11/14/2002	US20020169293 Microsphere for use in tools in the detection of preferential receptors and drug screening
11/14/2002	US20020169292 Human glycoprotein hormone for use in the prevention and treatment of metabolic and sexual disorders
11/14/2002	US20020169291 Interleukin-18 mutants, their production and use
11/14/2002	US20020169290 Nuclceotide sequences for use in the diagnosis, and prevent of multile sclerosis, viral infections, cancer, tumors, or tumour angiogenesis, and Chrohn's disease
11/14/2002	US20020169289 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
11/14/2002	US20020169287 Nucleotide sequences coding polypeptide for use in the treatment of eating, dieteticad energy disorders
11/14/2002	US20020169286 Peptide for use in the detection and prevention of epstein barr infections
11/14/2002	US20020169285 Polypeptide for use in the diagnosis, prevention and treatment of protozoan infections
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002	US20020169283 Nucleotide sequences coding polypeptides for use in the treatment of autoimmune diseases
11/14/2002	US20020169280 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
11/14/2002	US20020169279 Peptide for use in the prevention and treatment of bacterial infections
11/14/2002	US20020169264 Acylation with an acryloyl group of an amino group at some point in the peptide sequence, while still attached to the solid phase support with side chain groups intact, followed by deprotecting and free radical polymerization; vaccines
11/14/2002	US20020169139 Single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
11/14/2002	US20020169137 Preventing or inhibiting pathological beta-amyloid plaque formation in conditions such as Alzheimer's disease
11/14/2002	US20020169136 For detection of Babesia microti infection; in particular, invention is antigenic epitopes of such an antigen and the use of such polypeptides and antigenic epitopes for the serodiagnosis and treatment of B. microti infection
11/14/2002	US20020169133 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
11/14/2002	US20020169132 Polypeptides
11/14/2002	US20020169131 TGF-alpha polypeptides, functional fragments and methods of use therefor
11/14/2002	US20020169127 Compositions and methods for diagnosing or treating psoriasis
11/14/2002	US20020169126 E1A gene based anti-cancer therapy that targets cancers and tumors involving phospho-Akt expression (and/or Akt activation) and/or phospho-p38 downregulation (and/ or p38 inactivation)
11/14/2002	US20020169125 Fusion protein such as of polyglutamic acid and interferon-alpha; improves bioactivity and water-solubility properties of a drug to which it is conjugated
11/14/2002	US20020169121 Inhibiting tumor growth by inhibiting transcriptional activity of the transcription factor ATF2 which gives tumor cells apoptosis resistance; treating melanoma
11/14/2002	US20020169119 TGF-alpha polypeptides, functional fragments and methods of use therefor
11/14/2002	US20020169118 TNF receptors, TNF binding proteins and DNAs coding for them
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020169116 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/14/2002	US20020169115 Method of predicting resistance to hepatitis C infection
11/14/2002	US20020169110 Diagnosis of metastatic cancer by the mts-1 gene
11/14/2002	US20020169108 Identifying compounds capable of inhibiting fibronectin-mediated processes, by determining whether a candidate compound binds to a fibronectin Type III polypeptide; administering human uteroglobin
11/14/2002	US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence
11/14/2002	US20020169104 Novel ectoparasite saliva proteins and apparatus to collect such proteins
11/14/2002	US20020168769 Nucleotide sequences for use tools in generating genetic engineered plants
11/14/2002	US20020168762 B7-H3 and B7-H4, novel immunoregulatory molecules
11/14/2002	US20020168753 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
11/14/2002	US20020168752 Polypeptide for use in the treatment and prevention of cancer
11/14/2002	US20020168748 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections
11/14/2002	US20020168744 Amino acid sequence
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168735 Protein for use in the prevention of fungal infection
11/14/2002	US20020168731 Nucleotide sequences coding enzymatic polypeptide for use in the generation of threonine
11/14/2002	US20020168729 Human endokine alpha and methods of use
11/14/2002	US20020168728 Generation preferential proteins; obtain gram-negative prokaryotic cell, transform with nucleotide sequences coding protein, culture, recover protein
11/14/2002	US20020168727 Generation of botulinum neurotoxin light chain; culture cells coding botulinum neurotoxin light chain, express genes, recover protein
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168725 Protein for use in the diagnosis, treatment and prevention of nervous system disorders
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168723 Nucleotide sequences coding protein for use in the treatment of nervous system disorders
11/14/2002	US20020168722 Adjusted fibrinogen for use in the treatment blood clotting disorders
11/14/2002	US20020168721 TSG-like gene
11/14/2002	US20020168720 G protein coupled receptor proteins, their production and use
11/14/2002	US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
11/14/2002	US20020168718 Enzyme-mediated modification of fibrin for tissue engineering
11/14/2002	US20020168717 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/14/2002	US20020168714 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
11/14/2002	US20020168713 46980, a novel human neuroligin family member and uses thereof
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168709 Adjustment of gene expression
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168705 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
11/14/2002	US20020168702 Isolating cells expressing secreted proteins
11/14/2002	US20020168697 Antimicrobial methods and materials
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168689 Detecting nervous system disorders in animals; obtain tissue sample, incubate with antibody, detect bound antibody, determine concentration of bound antibody
11/14/2002	US20020168687 Inhibition of tau-tau-association
11/14/2002	US20020168683 Human pellino polypeptides
11/14/2002	US20020168675 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
11/14/2002	US20020168674 Amplifying and isolating preferential nucleotide sequences; obtain preferential nucleotide sequence library, incubate with primers, amplify nucleotide sequences, digest, recover preferential nucleotide sequences
11/14/2002	US20020168673 Mitofusins, Fzo homologs and functional derivatives thereof
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168668 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of neovascularization, cardiovascular, endothelial, kidney, lung, nervous system, pain and metabolic disorders
11/14/2002	US20020168662 Sperm protein 17 for the diagnosis and treatment of cancer
11/14/2002	US20020168653 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
11/14/2002	US20020168649 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement
11/14/2002	US20020168647 Compositions and methods for the therapy and diagnosis of head and neck cancer
11/14/2002	US20020168637 Polypeptide
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168627 Polypeptide for use in the treatment and prevention of viral diseases
11/14/2002	US20020168392 Antimicrobial proteins
11/14/2002	US20020168384 Vaccine for poultry respiratory disorders
11/14/2002	US20020168383 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
11/14/2002	US20020168382 Inducing immunology response
11/14/2002	US20020168381 Mixture of bone protein and ethylene oxide-propylene oxide copolymer; in situ administering
11/14/2002	US20020168380 Moderating immunology response
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	US20020168378 Autoimmune disease; anticancer agents
11/14/2002	US20020168377 Prion protein dimers useful for vaccination
11/14/2002	US20020168376 Plant extracts; sensitization of an animal; screening
11/14/2002	US20020168374 Hla binding peptides and their uses
11/14/2002	US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002	US20020168372 Dna sequence encoding a papillomavirus l1 protein capable of efficiently forming virus-like particles
11/14/2002	US20020168370 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
11/14/2002	US20020168367 Novel immunoadhesins for treating and preventing viral and bacterial diseases
11/14/2002	US20020168365 Method for modulating granzyme B uptake and for identifying modulators thereof

1 ... 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 ... 2916